How Much Did MARK A. SCHUSTERMAN, MD, FACS Raise?
Funding & Key Investors

Mark A. Schusterman, MD, FACS, a prominent Houston-based aesthetic surgery practice, has successfully secured a significant capital injection to bolster its operational footprint. The recent financing round, totaling $86K, underscores the clinic's robust market position and commitment to scaling its specialized cosmetic services. With a cumulative financial backing of $86K, the organization is well-positioned to enhance its service delivery model and invest in advanced medical technologies.

What is MARK A. SCHUSTERMAN, MD, FACS?

MARK A. SCHUSTERMAN, MD, FACS
Hospitals & Physicians ClinicsPhysicians ClinicsMedical Practice Management

Led by double-board certified surgeon Dr. Mark Schusterman, the clinic operates at the intersection of high-end aesthetic surgery and comprehensive MedSpa rejuvenation. The practice provides a diverse portfolio of surgical interventions, including breast augmentation, abdominoplasty, and facial rejuvenation, alongside non-surgical anti-aging treatments. By maintaining a focus on natural-looking outcomes and personalized patient care, the clinic has established a reputation that attracts both regional and international clientele. The current growth trajectory reflects a strategic shift toward institutionalizing its clinical operations to meet the rising demand for premium cosmetic healthcare in the Texas market.

How much funding has MARK A. SCHUSTERMAN, MD, FACS raised?

MARK A. SCHUSTERMAN, MD, FACS has raised a total of $86K across 1 funding round:

2021

Debt

$86K

Debt (2021): $86K with participation from PPP

Key Investors in MARK A. SCHUSTERMAN, MD, FACS

PPP

Public-Private Partnership

What's next for MARK A. SCHUSTERMAN, MD, FACS?

The infusion of capital is expected to facilitate a substantial expansion of the clinic's infrastructure and service capabilities. As the practice moves into its next phase of development, management will likely prioritize the integration of cutting-edge aesthetic technologies and the potential scaling of its MedSpa offerings. By leveraging this financial runway, the clinic aims to solidify its competitive advantage in the elective surgery sector, ensuring that it remains at the forefront of clinical innovation while maintaining the high standards of patient safety and aesthetic excellence that define its brand identity.

See full MARK A. SCHUSTERMAN, MD, FACS company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Hospitals & Physicians Clinics industry

Hospitals & Physicians ClinicsMedical & Surgical Hospitals
Hospitals & Physicians ClinicsPhysicians ClinicsMedical Practice Management
Hospitals & Physicians ClinicsMedical Practice ManagementHealthcare ServicesMedical Laboratories & Imaging Centers
Dental Practice ManagementHospitals & Physicians Clinics

Frequently Asked Questions Regarding MARK A. SCHUSTERMAN, MD, FACS Financial Insights

What are the most recent funding rounds that MARK A. SCHUSTERMAN, MD, FACS has completed, and what were the funding rounds?
MARK A. SCHUSTERMAN, MD, FACS has recently completed 1 funding rounds: Debt on Feb 11, 2021.
What is the total amount of funding MARK A. SCHUSTERMAN, MD, FACS has raised to date?
MARK A. SCHUSTERMAN, MD, FACS has raised a total of $86K in funding to date.
How many funding rounds has MARK A. SCHUSTERMAN, MD, FACS completed?
MARK A. SCHUSTERMAN, MD, FACS has completed 1 funding rounds.
How much funding did MARK A. SCHUSTERMAN, MD, FACS raise in its most recent funding round?
MARK A. SCHUSTERMAN, MD, FACS raised $86K in its most recent funding round.
Who are the lead investors in MARK A. SCHUSTERMAN, MD, FACS's latest funding round?
The lead investor in MARK A. SCHUSTERMAN, MD, FACS's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in MARK A. SCHUSTERMAN, MD, FACS's history?
The largest funding round in MARK A. SCHUSTERMAN, MD, FACS's history was $86K.
See more information about MARK A. SCHUSTERMAN, MD, FACS